Increasing age and disease progression negatively impact remyelination in Multiple Sclerosis. Here authors show that genetically edited human oligodendrocyte precursor cells may help overcome remyelination inhibitors and improve remyelination after transplantation into mouse brain.
- Laura J. Wagstaff
- Nadine Bestard-Cuche
- Anna C. Williams
